Type
Business expansion
Country
Ireland
Region
Southern and Eastern; South-West (IRL);
Location of affected unit(s)
Sector
Manufacturing
Manufacture Of Chemicals And Pharamceuticals
Manufacture Of Chemicals And Chemical Products
20 - Manufacture of chemicals and chemical products

250 jobs
Number of planned job creations
Job creation
Announcement Date
13 October 2003
Employment effect (start)
Foreseen end date

Description

Irish engineering firm, DPS Engineering, which specialises in providing services to the pharmaceutical sector, is planning to create 250 jobs over the next five years. The company intends to recruit mainly third-level graduates to serve in its three offices in Dublin, Cork and Holland.

Most of those recruited are expected to be engineers or scientists. A large proportion are expected to come from the universities or the institute of technology sector.

The company is Irish owned and has an annual turnover of €20 million. It draws most of its revenue from contracts with large pharmaceutical companies such as Schering Plough, Roche, Novartis, Warner Lambert, Pfizer and Eli Lilly.It advises and assists these companies in a range of areas from physical infrastructure to making sure their operations meet international standards.

DPS Engineering is going through a major growth phase. Since 1996, it has developed from a small scale engineering company with 25 employees to an operation currently employing 260 people.


Sources

  • 13 October 2003: The Irish Times

Citation

Eurofound (2003), Dedicated Pharmaceutical Specialists Engineering (DPS), Business expansion in Ireland, factsheet number 59348, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/59348.